Cargando…

A267 IDENTIFYING ENTEROBACTERIACEAE VIRULENCE GENES ASSOCIATED WITH ACTIVE DISEASE IN ULCERATIVE COLITIS PATIENTS USING CULTURE-DEPENDENT AND -INDEPENDENT APPROACHES

BACKGROUND: The prevalence of inflammatory bowel disease (IBD) in Canada is among the highest in the world and is estimated to affect 1 in 100 Canadians by 2030. Ulcerative colitis (UC) is a type of IBD characterized by mucosal inflammation of the large intestine. UC is believed to arise through a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tertigas, D, Rinawi, F, Griffiths, A, Surette, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991278/ http://dx.doi.org/10.1093/jcag/gwac036.267

Ejemplares similares

P267: Current aspects of acquired infection in maternity Issaka Gazobi hospital – Niamey, Niger
por: Djibo, H, et al.
Publicado: (2013)

Differential regulation of IL-22BP in Crohn’s disease versus ulcerative colitis
por: Martin, Jérôme, et al.
Publicado: (2011)

267. Characteristics and Trends of Serratia Blood Stream Infections
por: Elabd, Hatem, et al.
Publicado: (2020)

Differential association of two PTPN22 coding variants with Crohn’s disease and ulcerative colitis
por: Diaz-Gallo, L M, et al.
Publicado: (2010)

A186 ASSOCIATION OF ULCERATIVE COLITIS BOWEL URGENCY IMPROVEMENT WITH CLINICAL RESPONSE AND REMISSION
por: Clemow, D B, et al.
Publicado: (2023)

A77 THE ASSOCIATIONS OF OBJECTIVELY ASSESSED SEDENTARY TIME AND STEP COUNT ON ULCERATIVE COLITIS OUTCOMES
por: Chiew, B A, et al.
Publicado: (2023)

P02.87. Ayurvedic management of Ulcerative Colitis: a non-randomized, observational cinical study
por: Kalapi, P, et al.
Publicado: (2012)

Comparative risk factors for nosocomial New Delhi metallo-beta-lactamase (NDM-1) producing Enterobacteriaceae and non-carbapenemase producing (NCP) Enterobacteriaceae
por: Izharuddin, E, et al.
Publicado: (2015)

A215 EVALUATING THE COMPARABILITY OF CARE FOR PERSONS ADMITTED TO TORONTO AREA HOSPITALS WITH ACUTE SEVERE ULCERATIVE COLITIS
por: Vukovic, S, et al.
Publicado: (2023)

A167 HISTOLOGICAL REMISSION PLACEBO RATES IN ULCERATIVE COLITIS TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Youssef, M, et al.
Publicado: (2023)

P267 Candida in the biliary tract: extrapolative PK PD considerations
por: Rege, Sujata, et al.
Publicado: (2022)

Risk factor for mortality associated with carbapenem-resistant Enterobacteriacea infections
por: Carrilho, Cláudia MDM, et al.
Publicado: (2013)

267. Therapeutic Management of Bacterial Brain Abscess: An Overview of Diagnosis and Outcomes
por: Campioli, Cristina G Corsini, et al.
Publicado: (2021)

Peripheral blood leukocytes express differential chemokine receptor profiles in irritable bowel syndrome, Crohn’s disease and ulcerative colitis
por: Linton, Ludvig, et al.
Publicado: (2012)

A181 HIGHER CUMULATIVE HISTOLOGIC INFLAMMATORY BURDEN SCORE IS ASSOCIATED WITH THE RISK OF DEVELOPMENT OF COLORECTAL NEOPLASIA IN ULCERATIVE COLITIS
por: Graff, D, et al.
Publicado: (2023)

Production of virulence factors by species of Candida albicans isolated from urine culture
por: Wiebusch, Laura, et al.
Publicado: (2014)

INCF plasmids responsible by dissemination of bla(KPC) gene among enterobacteriaceae
por: Calisto, F, et al.
Publicado: (2011)

Prevalence of carriage of ESBL producing enterobacteriaceae in a Dutch teaching hospital
por: Moen, G, et al.
Publicado: (2011)

A184 EARLY SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-1 INDUCTION TRIAL
por: Danese, S, et al.
Publicado: (2023)

A185 SUSTAINED SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-2 MAINTENANCE TRIAL
por: Dignass, A, et al.
Publicado: (2023)

Multidrug resistance among P. aeruginosa and Enterobacteriaceae in US hospitals, 2000 to 2009
por: Zilberberg, M, et al.
Publicado: (2013)

Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
por: Clement, Clare, et al.
Publicado: (2015)

A204 COST-EFFECTIVENESS OF THERAPIES AFTER FAILURE OF CONVENTIONAL THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS IN THE CANADIAN HEALTHCARE SYSTEM
por: Hagerman, C, et al.
Publicado: (2023)

Euromech Colloquium 267
Publicado: (1990)

A microbiome approach to sepsis: development and case-study application of novel methods for detection and isolation of microbes from whole blood
por: Crowder, M Faria, et al.
Publicado: (2012)

A190 THE IMPACT OF BOWEL URGENCY ON THE LIVES OF PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
por: Schreiber, S, et al.
Publicado: (2023)

A209 ASSESSMENT OF OUTCOMES OF PATIENTS ADMITTED WITH ACUTE, SEVERE ULCERATIVE COLITIS ON ESTABLISHED BIOLOGIC THERAPY: A SINGLE CENTRE RETROSPECTIVE ANALYSIS
por: Sabrie, N, et al.
Publicado: (2023)

Utility of Xpert Carba-R® in diagnostic laboratory for early detection of carbapenems resistant Enterobacteriaceae
por: Aljohani, S, et al.
Publicado: (2015)

Culture-Dependent and Culture-Independent Methods in Evaluation of Emission of Enterobacteriaceae from Sewage to the Air and Surface Water
por: Korzeniewska, Ewa, et al.
Publicado: (2012)

Fecal S100A12 levels measured by a new ELISA are increased in ulcerative colitis (UC) and Crohn’s disease (CD) and correlates with intestinal damage
por: Garnero, P, et al.
Publicado: (2010)

A200 HIGH-DEFINITION CHROMOENDOSCOPY RESULTS IN MORE SIGNIFICANT DYSPLASIA DETECTION THAN WHITE LIGHT ENDOSCOPY WITH RANDOM BIOPSIES IN ULCERATIVE COLITIS PATIENTS
por: Hoang, T T, et al.
Publicado: (2023)

NO inhibits platelet apoptosis by cGMP-dependent and-independent pathways
por: Rukoyatkina, Natalia, et al.
Publicado: (2009)

P081: Cefepime-tazobactam: a new antibiotic against ESBL producing enterobacteriaceae in cancer patients
por: Biswas, S, et al.
Publicado: (2013)

Prevalence of extended-spectrum betalactamase producing–Enterobacteriaceae (ESBL-E) carriage on admission at Geneva University Hospitals (HUG)
por: Fankhauser, C, et al.
Publicado: (2015)

Extended spectrum-beta-lactamase producing Enterobacteriaceae causing nosocomial infection in a tertiary care hospital, Nepal
por: Sah, MK
Publicado: (2015)

A216 BOWEL URGENCY COMMUNICATION GAP BETWEEN HEALTH CARE PROFESSIONALS AND PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
por: Travis, S, et al.
Publicado: (2023)

Microcirculatory hyporesponsiveness in lipopolysaccharide-induced inflammation is endothelial cell dependent but calcium independent
por: Ouellette, Y
Publicado: (2006)

A165 FCGBP IN THE COLON IS SPATIALLY DEPENDENT ON MUC2 EXPRESSION AND IS DEGRADED IN DEXTRAN SULFATE SODIUM-INDUCED COLITIS
por: Kim, A, et al.
Publicado: (2023)

PReS-FINAL-2080: Overlap syndrome between primary sclerosing cholangitis and autoimmune hepatitis associated with ulcerative colitis - a case of unusual presentation in a patient with systemic juvenile idiopathic arthritis
por: Cabral, M, et al.
Publicado: (2013)

A104 INVISIBLE COLONIC MALIGNANCY AND POSSIBLE IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY FROM VEDOLIZUMAB IN A PATIENT WITH ULCERATIVE COLITIS, PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS OVERLAP SYNDROME
por: Malhi, G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lsjftmq2eg8550gop6fq732d79